Bain Capital Europe
Key facts
Recent exits
Coverage notes
7 funds tracked, 20 portfolio companies (18 active · 2 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Bain Capital Europe has raised, with its portfolio companies. Hand-checked from public filings.
Bain Capital Real EstateReal Estate2025 · 1yr1 active
Bain Capital Europe Buyout Fund VIBuyout2023 · 3yr€6.3B3 active
Bain Capital Private EquityBuyout2021 · 5yr2 active
Unrealized
2 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Reiff | Industrials | Germany | – |
| Valeo Foods | Consumer | Ireland | – |
Bain Capital Europe Buyout Fund VBuyout2020 · 6yr€3.5B1 active
Bain Capital Special Situations Europe2018 · 8yr€1.2B1 active
Bain Capital Europe Fund IVBuyout2017 · 9yr9 active · 1 realized
Unrealized
9 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Bc Tvp Video Menu | TMT | US | – |
| Bcsi25 Cover | Energy | – | – |
| Fedrigoni | Industrials | Italy | – |
| Fintyre | Consumer | Italy | – |
| Gettys 1942702729 | TMT | US | – |
| Homepage Banner | TMT | US | – |
| Namirial | Software | Italy | – |
| Parts Holding Europe | Industrials | Europe | – |
| Quest Global Services | Business Services | India | – |
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| STADA Arzneimittel | Healthcare | Germany | – | 2026 | Trade Sale | – |
Bain Capital Europe Fund IIIBuyout2008 · 18yr€3.5B0 active · 1 realized
Saved GPs appear in your watchlist, one click from your workspace.
About Bain Capital Europe
Bain Capital Europe is a American private equity and investment platform with capital deployed across 7 active fund vehicles, headquartered in New York. The firm operates across multiple alternative strategies, with capital deployed into European businesses across industrials, TMT, consumer, business services, financials and energy.
Investment thesis
Bain Capital Europe operates across complementary alternative investment strategies, deploying capital into European businesses across industrials, TMT, consumer, business services, financials and energy. The multi-strategy platform enables diversified capital deployment across the business lifecycle from venture and growth equity to mid-cap buyouts, with capital sourced from institutional limited partners and selective family-office capital across North America with selective European deployment.
Recent activity
Recent realised exits include STADA Arzneimittel (healthcare, 2026). The platform tracks 7 fund vehicles, 17 active portfolio companies and 1 realised exit across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
United States·€700MUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited States